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Periodontal disease results from the interaction between pathogenic bacteria that colonize
supragingival and subgingival bioﬁlms and the host, triggering an inﬂammatory response,
with  systemic effects leading to immune-mediated destruction of the attachment appara-
tus and loss of supporting alveolar bone. Immunological pathways and predisposing genetic
factors common to periodontal disease and rheumatic diseases, including systemic lupus
erythematosus, have been described. Case reports have suggested greater severity of peri-
odontal disease in patients with systemic lupus erythematosus. However, studies evaluating
the inﬂuence of the treatment of one disease on the clinical and laboratory manifestations
of  the other have yielded conﬂicting results.
© 2015 Elsevier Editora Ltda. All rights reserved.
Há  associac¸ão  entre  o  lúpus  eritematoso  sistêmico  e  a  doenc¸a
periodontal?
r  e  s  u  m  oPalavras-chave:
Lúpus eritematoso sistêmico
Periodontite
Periodontite crônica
A doenc¸a periodontal resulta da interac¸ão entre bactérias patogênicas que colonizam os
ﬁlmes supra e subgengival e o hospedeiro e deﬂagram uma resposta inﬂamatória local, com
efeitos sistêmicos, que leva à destruic¸ão imunomediada dos tecidos de sustentac¸ão dos
dentes e do osso alveolar. Vias imunológicas e fatores genéticos predisponentes comuns
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à doenc¸a periodontal e às doenc¸as reumáticas, entre elas o lúpus eritematoso sistêmico,
vêm sendo descritos. Relatos de caso sugeriram maior gravidade da doenc¸a periodontal
em pacientes com lúpus eritematoso sistêmico. No entanto, estudos que avaliaram as
inﬂuências do tratamento de uma sobre as manifestac¸ões da outra apresentaram resultados
conﬂitantes.
© 2015 Elsevier Editora Ltda. Todos os direitos reservados.
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urrently, the relationship between connective tissue diseases
nd periodontal disease (PD) has been the subject of much
iscussion.1
PD is a group of infectious and inﬂammatory diseases that
esult from the interaction between periodontal pathogens
resent in supragingival and subgingival bioﬁlms and the
ost, generating an inﬂammatory response of variable inten-
ity, which can lead to immune-mediated destruction of the
ttachment apparatus and loss of supporting alveolar bone.
ingivitis, the most common form of periodontal disease, is
n inﬂammatory process characterized by erythema, edema
nd gingival bleeding. Periodontitis is characterized by gingi-
al inﬂammation accompanied by an inﬂammatory response
y the host, which results in destruction of the attachment
pparatus and loss of supporting alveolar bone and that have
ystemic effects. The changes found in dental evaluation of
eriodontitis are an increase in probing depth (probing pocket
epth – PPD), which reﬂects the distance from the bottom
f the pocket to the gingival margin, the presence of clini-
al attachment loss (CAL), which measures the position of the
oft tissue in relation to the cemento-enamel junction, and
he occurrence of gingival bleeding on probing (BOP), mobility
nd tooth and alveolar bone loss.2
The existence of immune pathways and of a genetic predis-
osition common to PD and connective tissue diseases, among
hese systemic lupus erythematosus (SLE), is recognized and
as been described.1
In this brief communication, we  reviewed studies pub-
ished in English or Portuguese, which investigated possible
ssociations between PD and SLE, found through a system-
tic search in PubMed/Medline and LILACS databases, using
he terms “Lupus Erythematosus, Systemic” and “Periodon-
itis”, “Periodontitis, Chronic” or “Periodontitis, Adult”. There
as no restriction about the search period. Twenty-two arti-
les from PubMed/Medline and ﬁve articles from LILACS were
ound. Thirteen original articles that dealt with the topic were
ncluded in this review.3–15 A manual search of the references
f included articles was carried out, and ﬁve articles were
elected.16–20
tudies  of  association  between  SLE  and
eriodontal  diseasease reports suggesting that clinical and therapeutic associ-
tions between SLE and PD have been published since the
980s,3–5 reporting a greater severity of PD in patients withSLE, probably associated with immunosuppression caused by
the disease, or its treatment.
The frequency of periodontitis in SLE patients varied in dif-
ferent studies, between 60 and 93.8% (Table 1).6–11 A Japanese
study reported that SLE patients had a higher frequency of
PD versus the general population of that country,9 but no
study has compared the frequency of PD with a control group
(healthy volunteers). The variability of the frequency of peri-
odontitis found in different studies is probably associated with
the use of different criteria for its diagnosis, or to differences
in patient groups with SLE with regard to disease severity or
activity. Thus, the question of frequency of periodontitis in
patients with SLE remains an open one, and controlled stud-
ies are needed for setting up whether periodontitis is actually
more  common in SLE patients.
Several authors evaluated the severity of PD in SLE
patients compared to healthy volunteers, or to patients with
PD without SLE, and their results were conﬂicting. Peri-
odontal parameters were found to be: similar,9,10,12,13 less
severe,9,10,13–15 or more  severe16–18 (Table 2).
These controversial data prompted some questions as:
immunosuppression induced by SLE or its treatment would
increase, would not affect, or would reduce the infectious
and inﬂammatory periodontal destruction? The studies that
found lower severity of periodontal parameters in SLE suggest
a smaller immune-mediated periodontal destruction asso-
ciated with immunosuppressive drugs.9,10,13–15 However, the
composition bias of the control group, consisting primarily
of patients referred for specialized treatment and potentially
with more  serious periodontitis, was not controlled. Studies
were also published that suggest a greater severity of PD in
patients with SLE, especially when the disease is active.16–18
Then, immunosuppression would increase the periodontal
decay associated with chronic infection? This point also is not
deﬁned and requires further studies that include patients with
active and inactive SLE, evaluating the inﬂuence of SLE activ-
ity and of the immunosuppressive treatment on periodontal
parameters, with the inclusion of a control group representa-
tive of the general population, with people with and without
PD.
Biological  basis  of  the  association  between  SLE
and PD
In PD, the gum infection triggers a series of immune responses
that involve the participation of immune cells and cytokines,
that results in the destruction of the attachment appara-
tus and alveolar bone loss. A study reported an increase
of serum levels of C-reactive protein (CRP) and of salivary
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Table 1 – Periodontitis frequency in patients with SLE.
Study Number of patients
with SLE
Frequency of periodontitis
observed
Frequency of periodontitis
in general population
Rhodus and Johnson6 16 93.8% Not reported
Novo et al. 7,8 30 60% Not reported
Kobayashi et al. 9 60 70% 30–40%
Kobayashi et al. 10 71 
Fabbri et al. 11 55 
and serum levels of various cytokines, including: IL-1, IL-
1, IL-6, IL-8, TNF-, TNF-, IFN- (inﬂammatory) and IL-10
(anti-inﬂammatory).19
The receptors for the constant region of immunoglobulin G
(FcR) participate in the immune response, facilitating phago-
cytosis by opsonization and acting in antibody-dependent
cellular cytotoxicity and in the activation of the toxic gran-
ule release by inﬂammatory cells. There is evidence of an
association between certain genetic polymorphisms of genes
encoding these receptors and infectious and autoimmune
diseases. Kobayashi et al. 9,10 found higher expression of
FcRIIa-R131 allele in patients with SLE and periodontitis
Table 2 – PD severity classiﬁcation in SLE patients and the inﬂu
Study Study design Patients included 
Mutlu et al.14 Case–control 27 SLE
25 controls
Meyer et al.12 Case–control 46 SLE
50 controls
Kobayashi et al.9 Case–control 42 SLE + PD
42 PD
Souza13 Case–control 16 JSLE
14 controls
Miceli et al.15 Case–control 17 JSLE
14 controls
Kobayashi et al.10 Case–control 46 SLE + PD
48 PD
Fernandes et al.16 Case–control 48 JSLE
48 controls
Umbelino Jr. et al.17 Case series 155 SLE 
Meyer et al.18 Case series 46 SLE 
Sales et al.20 Series of cases submitted to
clinical treatment of PD.
6 SLE + PD 
Fabbri et al.11 Randomized, controlled
trial on PD treatment.
49 SLE + PD:
32 treated
17 untreated
SLE, systemic lupus erythematosus; PD, periodontal disease (periodontitis
bleeding index; ABL, alveolar bone loss; SP%, percentage of sites with plaqu
systemic lupus erythematosus; SLEDAI, Systemic Lupus Erythematosus Dis
level; ESR, erythrocyte sedimentation rate.64.8% Not reported
89% Not reported
versus patients with SLE but without periodontitis, and also
healthy volunteers.9 These authors have also shown that
patients with SLE and periodontitis exhibited the combina-
tion of polymorphisms FcRIIa-R131 and FcRIIB-232T more
often than SLE patients without periodontitis, patients with
periodontitis but without systemic disease, and healthy vol-
unteers. Combined alleles also were associated with greater
severity of periodontal parameters in patients with SLE.10
On the other hand, so far, studies have not identiﬁed an
association between periodontitis or periodontal evaluation
parameters and evidence of inﬂammatory activity (ESR and/or
CRP) in SLE or SLEDAI.13,16
ence of treatment of a disease over the other.
Assessed outcomes Results
PPD Lower in SLE.
VPI, GBI, BOP% Similar.
PPD, CAL, SP%, BOP% Smaller PPD, CAL and BOP% in
SLE. Similar SP% and BOP%.
VPI, GBI, CAL, PPD Lower percentage of sites with
PPD ≥3 mm in JSLE. Similar VPI,
GSI and percentage of sites with
CAL ≥2 mm. Active JSLE
presented higher VPI and GSI
versus inactive JSLE.
PPD Lower percentage of sites with
PPD ≥4 mm in SLE.
PPD, CAL, BOP%, SP% Lower PPD, CAL, BOP%, and SP%
in SLE. Similar SP%.
VPI, GBI Higher in JSLE. Cumulative
prednisone dosage correlated to
VPI and GBI.
Dental calculus, gingival
bleeding, periodontal
pockets.
Gingival bleeding and
periodontal pockets were greater
in SLE patients, when compared
to epidemiological data from
general population.
Oral mucosa lesions, teeth
loss, gingival inﬂammation.
Greater in patients with severe
SLE.
Bacterial plaque, BOP% and
PPD, SLEDAI, CRP.
Improvement of periodontal
parameters with no changes of
SLEDAI.
PPD, CAL, GBI, SLEDAI, CRP,
ESR.
Improvement of periodontal
parameters and SLEDAI on
treatment group
); PPD, probing pocket depth; VPI, visible plaque index; GBI, gingival
e; BOP%: percentage of sites with bleeding on probing; JSLE, juvenile
ease Activity Index; CRP, C-reactive protein; CAL, clinical attachment
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from http://www.uptodate.com/contents/gingivitis-and-
periodontitis-in-adults-classiﬁcation-and-dental-
treatment?source=search result&selectedTitle=1%7E97r e v b r a s r e u m a t o l
Two studies examined inﬂammatory cytokines in gingival
revicular ﬂuid (which can be found in periodontal pockets)
nd in serum. Souza13 found higher crevicular ﬂuid levels of
otal and free elastase and lower crevicular ﬂuid levels of IL-
8, but higher serum levels of IL-18 in patients with juvenile
LE versus control group. CAL showed a negative correlation
ith crevicular ﬂuid IL-18 levels (r = −0.5; p < 0.05), suggesting
hat this cytokine could have a protective effect on the tissue
estruction associated with PD. In the study by Miceli et al.,15
ealthy adolescents had higher levels of IL-1- in crevicular
uid versus patients with juvenile SLE who were evaluated for
resence of periodontal disease.
Two studies evaluated the association between the pres-
nce of antineutrophil cytoplasmic antibodies (ANCA) and
eriodontitis in subjects without rheumatic disease and in
atients with SLE or rheumatoid arthritis (RA).7,8 Half of the
ubjects with periodontitis were positive for ANCA. Among the
8 patients with SLE and periodontitis, 83.3% were positive for
NCA. Half of the patients with RA had periodontitis, but this
isease was not associated with a higher occurrence of ANCA.
he signiﬁcance of the association between ANCA and peri-
dontitis in healthy subjects or in patients with SLE remains
nclear.7,8
In summary, there is evidence of a common genetic predis-
osition (shared polymorphisms) of SLE and PD, which could
xplain the association between these two conditions. Still, at
east from a theoretical point of view, there are pathophysio-
ogical mechanisms common to PD and LES that need to be
etter described and understood, because they may represent
rospects for future therapeutic approaches.
peciﬁc  treatment  and  inﬂuence  on  SLE  and
eriodontal  disease
ernandes et al.16 found a positive correlation between the
umulative dose of corticosteroids and increases in plaque
nd gingival bleeding rates in patients with juvenile SLE
respectively, r = 0.385, p = 0.01; r = 0.471; p = 0.001), but did
ot identify an association with the use of antimalarials or
mmunosuppressive agents (Table 2).16
Two studies evaluated the inﬂuence of the treatment of PD
n SLE activity (Table 2). Sales et al.20 selected six patients with
LE (mean of SLEDAI = 3.5) and PD. The patients underwent
on-surgical treatment of periodontitis and were reassessed
5 days after its completion. There was signiﬁcant improve-
ent in their periodontal indices. SLEDAI and CRP levels did
ot change signiﬁcantly after periodontal treatment.20
Fabbri et al.11 selected 49 patients with active SLE and
D, divided into two groups: one group with treatment of PD
erformed during the study (n = 32) and a group whose treat-
ent of PD was delayed for a time after completion of the
tudy. There was no signiﬁcant difference in baseline SLEDAI
n treated and control groups. Patients were reassessed 3
onths after the treatment of PD, when a signiﬁcant reduc-ion in SLEDAI was observed in the treatment group (5.9 ± 4.2
s. 3.4 ± 3.3, p = 0.04), but did not occur in the untreated group.
No signiﬁcant differences were noted in ESR or CRP in both
roups (Table 2).11 6;5 6(3):280–284 283
The highest cumulative dose of corticosteroids, given local
and systemic immunosuppressive and metabolic effects of
these agents (with an interference in bone metabolism), could
be associated with the worst outcome of the infectious pro-
cess and, consequently, with greater periodontal destruction
in patients with SLE and PD. Studies are needed to establish
whether the concomitant use of immunosuppressants would
have a protective effect or, on the contrary, would contribute
to greater periodontal destruction in SLE and PD patients.
Studies evaluating the inﬂuence of PD treatment on SLEDAI
in SLE patients showed conﬂicting results. One study, which
showed no change in SLEDAI, included a small number of
patients without high activity of the disease.20 Another study
evaluated a greater number of patients with active SLE, all
on monthly intravenous infusions of cyclophosphamide and
corticosteroids, and showed signiﬁcant decline in SLEDAI,
compared to baseline, in patients treated for periodontitis,
which did not occur in the group untreated for this disease;
this suggests a possible role of the treatment of periodontitis
in the control of active SLE.11 This result is quite interesting,
because it opens up promising prospects in SLE approaches,
however it must be conﬁrmed by prospective controlled stud-
ies. Theoretically, the control of chronic infection related to
PD could reduce the degree of activation of the immune sys-
tem, favoring the response of SLE to the immunosuppressive
treatment.
Conclusion
The data about possible associations between SLE and PD
are controversial. The good clinical practice, however, recom-
mends attention to the oral health of patients with SLE, ideally
with periodic dental evaluation. In the event of PD identiﬁca-
tion, its treatment should be performed, as it can positively
inﬂuence the however of SLE. Further studies will be needed to
establish the association between SLE and PD, as well as their
biological basis, and to clearly deﬁne the effect of treatment
of a condition over the other.
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